Aurobindo Pharma FY10-11 Results : Net profit rises 13%

by khalid on 10/05/2011 · 0 comments

Aurobindo Pharma Limited (APL) has posted an increase in net profit for the full financial year FY11 (ending Mar 2011). During the said period, net profit rises 13% to Rs 594 crore in comparison to the Rs 526 crore of full financial year FY10 (ending Mar 2010) of previous year. Aurobindo Pharma Limited (APL) is one of the largest API manufacturers in Asia and has commercialised over hundred APIs.

The company informed the share market(BSE) that the net income/sales increased 27% to Rs 4133 crore in the full financial year FY11 (ending Mar 2011) when compared with the last years same period of full financial year FY10 (ending Mar 2010) of previous year which was Rs 3252 crore.

Share’s Data :-
BSE Code : 524804
Market Cap : Rs 5,385.35 Crores
Aurobindo Pharma Ltd. share’s CMP is Rs 184.75 on 10th May 2010.

Stay tuned to BelltheBull Blog for more news on Aurobindo Pharma Limited (APL) !

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: